Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-25-000042
Filing Date
2025-02-07
Accepted
2025-02-07 13:21:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5498
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 5775
  Complete submission text file 0000914208-25-000042.txt   13437
Mailing Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309
Business Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88843 | Film No.: 25600707
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)